Skip to main content
Midas Edge

BRIGHT MINDS BIOSCIENCES INC.

For the period ended Sep 30, 2025. Filed Dec 23, 2025.

View on SEC.gov

About this filing

The yearly report of certain Canadian companies, filed under a joint US and Canadian system. It is the main yearly account these companies give US investors, largely as filed in Canada.

FY2025 · Filed Dec 23, 2025

Use the contents to explore the available documents and sections.

DRUG$23.00+11.1%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.3 · OUTSTANDING SHARE DATA

OUTSTANDING SHARE DATA

The Company’s share capital as of date of this MD&A is:

Balance
Shares issued and outstanding7,787,161
Share purchase warrants361,765
Restricted share units77,150
Stock options388,750
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.